Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.

Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (0)

No references identified in the available metadata. This does not establish that none exist.

    Cited by — these papers cite this paper (199)

    1. Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery model 2026-12-01 · Expand citations
    2. Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement 2026-12-01 · Expand citations
    3. Changes in self-related cognitive processes and depressive symptom severity following a single, moderate dose of psilocybin in depressed patients 2026-11-10 · Expand citations
    4. Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression 2026-11-01 · Expand citations
    5. Safety and Efficacy of Psilocybin During Anticancer Treatment: A Phase II Trial Secondary Analysis 2026-11-01 · Expand citations
    6. The 'Civilising' of Psychedelics: Pharmaceuticalisation from Below as a Part-Process of American and European Informalisation 2026-10-30 · Expand citations
    7. Clinical Evidence on Psilocybin and Its Representation in Media Reporting 2026-10-20 · Expand citations
    8. Psychedelics in neurosurgery: Potential utility in prevention, perioperative care, pain management, and neurorehabilitation 2026-10-09 · Expand citations
    9. Efficacy and safety of psilocybin-assisted therapy for alcohol use disorder: A systematic review and meta-analysis 2026-10-08 · Expand citations
    10. Study participant perceptions of the relevance of therapist and study team personal psychedelic experience 2026-10-03 · Expand citations
    11. A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose Study to Identify a Subperceptual Dose of Psilocybin in Healthy Adults 2026-09-21 · Expand citations
    12. Mystical but not challenging experiences predict symptom improvement after psilocybin for treatment-resistant OCD 2026-09-08 · Expand citations
    13. Through the Looking-Glass: A Scoping Review of Psychological Mechanisms of Psychedelic-Assisted Therapy for Substance Use Disorders 2026-09-02 · Expand citations
    14. PSYCHEDELICS IN THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER AND DEPRESSION: A REVIEW OF CLINICAL TRIALS 2026-08-31 · Expand citations
    15. Ayahuasca and Salvia divinorum as contrasting modes of consciousness reorganization: Implications for psychedelic-assisted psychotherapy 2026-08-13 · Expand citations
    16. Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026) 2026-08-12 · Expand citations
    17. Psychedelic integration beyond the verbal: participatory-imaginal processing as a hypothesis-generating therapeutic framework 2026-08-12 · Expand citations
    18. The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis 2026-08-01 · Expand citations
    19. Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial 2026-07-30 · Expand citations
    20. Integration in classic psychedelic-assisted therapies for mental health conditions: A scoping review 2026-07-26 · Expand citations
    21. Longitudinal neural and psychological changes following psilocybin under compassion imagery priming 2026-07-22 · Expand citations
    22. Learnings from a hybrid communities of practice group therapy model to support psilocybin-assisted therapy for patients with a terminal diagnosis 2026-07-20 · Expand citations
    23. Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorder 2026-07-16 · Expand citations
    24. Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview 2026-07-13 · Expand citations
    25. Trajectories of psychedelic-assisted change: An observational study of a psilocybin retreat program followed by psychotherapeutic interventions 2026-07-03 · Expand citations
    26. Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholders 2026-07-01 · Expand citations
    27. Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in rats 2026-07-01 · Expand citations
    28. Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults” 2026-06-30 · Expand citations
    29. Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex 2026-06-28 · Expand citations
    30. DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in Zebrafish 2026-06-18 · Expand citations
    31. THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRY 2026-06-14 · Expand citations
    32. Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World Implementation 2026-06-03 · Expand citations
    33. Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations 2026-06-01 · Expand citations
    34. Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial 2026-06-01 · Expand citations
    35. Psilocybin: Chemical Foundations and Emerging Therapeutic Potential 2026-06-01 · Expand citations
    36. Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis 2026-05-29 · Expand citations
    37. Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression 2026-05-15 · Expand citations
    38. Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care 2026-05-14 · Expand citations
    39. Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilization 2026-05-13 · Expand citations
    40. Psilocybin in the Treatment of Cocaine Use Disorder 2026-05-07 · Expand citations
    41. Human brain changes after first psilocybin use 2026-05-05 · Expand citations
    42. Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamine 2026-05-01 · Expand citations
    43. Insights into psilocybin use among people with bipolar disorder: A thematic analysis of Reddit posts 2026-05-01 · Expand citations
    44. Prevalence and Correlates of Past-Year Psilocybin Use in the U.S., 2024, USA 2026-05-01 · Expand citations
    45. Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanisms 2026-05-01 · Expand citations
    46. Therapeutic Potential of Psilocybin in Alcohol and Opioid Use Disorders: A Promising Role for Psychedelics 2026-04-30 · Expand citations
    47. The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes 2026-04-21 · Expand citations
    48. A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience 2026-04-14 · Expand citations
    49. Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study Protocol 2026-04-13 · Expand citations
    50. Sex-specific increased reactivity of the PVT and prolonged PVT→CeA circuit engagement following psilocin administration 2026-04-10 · Expand citations
    51. Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression 2026-04-09 · Expand citations
    52. A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depression 2026-04-06 · Expand citations
    53. Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis 2026-04-01 · Expand citations
    54. Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications 2026-04-01 · Expand citations
    55. Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studies 2026-03-31 · Expand citations
    56. Associations Between Psilocybin Use Motives and Cognitive, Affective, and Behavioural Self-Stigma 2026-03-28 · Expand citations
    57. Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD) 2026-03-26 · Expand citations
    58. “You can only take your clients as far as you’ve been yourself”: examining the intersections between psychedelic-assisted therapy, lived-living experience, and clinical practice 2026-03-22 · Expand citations
    59. Psilocybin or Nicotine Patch for Smoking Cessation 2026-03-10 · Expand citations
    60. Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping review 2026-03-09 · Expand citations
    61. Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy 2026-03-01 · Expand citations
    62. A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations 2026-02-28 · Expand citations
    63. Pilot study of psilocybin in patients with post-treatment lyme disease 2026-02-25 · Expand citations
    64. Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain Exposure 2026-02-12 · Expand citations
    65. Low-income group psilocybin assisted therapy for depression: An Oregon feasibility study 2026-02-12 · Expand citations
    66. Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexia 2026-02-03 · Expand citations
    67. THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS 2026-01-22 · Expand citations
    68. Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 Study 2026-01-18 · Expand citations
    69. Intentions, Spirituality, Set, and Setting Are Associated with Mystical Experiences in Psilocybin-Assisted Therapy 2026-01-12 · Expand citations
    70. The genus Psilocybe in Italy 2025-12-22 · Expand citations
    71. Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational Study 2025-12-19 · Expand citations
    72. Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto Rats 2025-12-16 · Expand citations
    73. Psilocybin and MDMA in Couples Therapy: Investigating Treatment for Substance Use Disorders and Codependency 2025-12-11 · Expand citations
    74. Unlocking the power of tryptamine alkaloids in Psilocybe fungi: chemistry, mental health potential and legal challenges 2025-12-08 · Expand citations
    75. Meaning and Purpose Therapy Modified for Psilocybin (P-MaP): A Treatment Model for Palliative Care Patients 2025-12-01 · Expand citations
    76. Psychedelics for the Treatment of Substance Use Disorders 2025-12-01 · Expand citations
    77. Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Disorders: A Scoping Review 2025-11-24 · Expand citations
    78. Interactions between psilocybin, LSD, and serotonergic antidepressants: A qualitative analysis of user reports 2025-11-20 · Expand citations
    79. Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondents 2025-11-15 · Expand citations
    80. A Comparative Neurophenomenology of the Psychedelic State and Autism: Predictive Processing as a Unifying Lens 2025-11-14 · Expand citations
    81. Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted Therapy 2025-11-02 · Expand citations
    82. Multianalytical Investigation of Psilocybe cubensis Mushrooms: Physicochemical Characterization and Biological Evaluation of Psilocybin and Psilocin Compounds 2025-09-30 · Expand citations
    83. Ethical challenges in the therapeutic application of classical psychedelics for pediatric health conditions: A comprehensive review 2025-09-29 · Expand citations
    84. The Legal Perspective on Psilocybin for Medical Use in Czechia: A Key Milestone and the Case for Broader Consideration Beyond the Clinical Setting 2025-09-11 · Expand citations
    85. Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder 2025-09-04 · Expand citations
    86. Neuroplasticity and Neuro-Generation: The Promise of Psychedelics in Dementia Care 2025-09-02 · Expand citations
    87. “To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group Therapy 2025-08-25 · Expand citations
    88. The psychedelic renaissance: psilocybin, a breakthrough for treatment resistant depression? 2025-08-07 · Expand citations
    89. Rise of the Mushrooms: Effects of Psilocybin Reforms on Psychedelic Usage Patterns 2025-07-16 · Expand citations
    90. Psilocybin Use in an Intercollegiate Athlete with Persisting Symptoms After Concussion: A Case Report 2025-07-01 · Expand citations
    91. Increasing the Evaluation and Reporting Rigor of Psychotherapy Interventions in Treatments Involving Psychedelics 2025-06-29 · Expand citations
    92. Is there mush-room to improve the environmental sustainability of psilocybin production? 2025-06-10 · Expand citations
    93. Mystical States & Psilocybin. From Dissociation Towards Association: A Conversational Model Discussion 2025-05-31 · Expand citations
    94. Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische Anwendung 2025-05-01 · Expand citations
    95. Improving Best Practice Indicators for Psilocybin Assisted Therapy Using a Mul-tiphase Mixed Methods Delphi Study 2025-04-30 · Expand citations
    96. Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile Analysis 2025-04-24 · Expand citations
    97. Exploring the perceived usefulness of integration support after naturalistic psychedelic experiences in people concerned about their substance use: A survey 2025-04-22 · Expand citations
    98. Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans 2025-04-21 · Expand citations
    99. Minorities’ diminished psychedelic returns: Depression, suicide, distress, and serious mental illness 2025-04-01 · Expand citations
    100. The renaissance of psychedelics in modern psychiatry: a new breakthrough or the myth of a “magic bullet”? 2025-03-14 · Expand citations
    101. BROAD SPECTRUM OF THERAPEUTIC PROPERTIES OF PSILOCYBIN: A LITERATURE REVIEW 2025-02-20 · Expand citations
    102. Moral Considerations and the Experience of Ego Dissolution: Insights from Psilocybin 2025-01-01 · Expand citations
    103. The effects of psychedelics on neuroplasticity: A review of current research and the possibility of therapeutic application in psychiatry 2025-01-01 · Expand citations
    104. Narrative review of psilocybin, an important psychoactive substance with potential peri-anesthetic implications 2024-11-30 · Expand citations
    105. Psilocybin-assisted psychotherapy as an ‘anti-distressant’ with multidimensional properties 2024-10-14 · Expand citations
    106. Memory, trauma, and self: Remembering and recovering from sexual abuse in psychedelic-assisted therapy 2024-10-09 · Expand citations
    107. Rapid and Prolonged Antidepressant and Antianxiety Effects of Psychedelics and 3,4-Methylenedioxy-methamphetamine-A Systematic Review and Meta-Analysis 2024-10-03 · Expand citations
    108. Psychedelics as novel therapeutic agents for chronic pain: mechanisms and future perspectives 2024-09-24 · Expand citations
    109. Change in occupational burnout measures in emergency medical service workers after a psychedelic experience induced by a single self-administered dose of psilocybin mushrooms 2024-09-09 · Expand citations
    110. Psychedelic-assisted therapy: Magical thinking or a meaningful treatment for mental illness 2024-09-04 · Expand citations
    111. Psychedelic use and psychological flexibility: The role of meaningful intention and decentering 2024-08-16 · Expand citations
    112. Psilocybin - A Drug to be Considered for the Treatment of Anxiety and Depression in Cancer Patients 2024-07-31 · Expand citations
    113. PTSD Treatment: An Inquiry into the Promising Potential of Psilocybin 2024-07-24 · Expand citations
    114. Psychedelic trip sitting, dosages and intensities: Supplementing clinical studies with anecdotal reports 2024-07-17 · Expand citations
    115. Assessment of psychedelic--induced states: Norwegian translation and adaptation of the revised Mystical Experience Questionnaire (MEQ-30) 2024-07-12 · Expand citations
    116. Historical Perspectives and Pharmacodynamic Actions of the Magic Mushroom (Psilocybin) for Future Global Healthcare 2024-06-28 · Expand citations
    117. In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin 2024-04-29 · Expand citations
    118. Therapeutics Uses of Psychedelics in patients with psychiatric disorders A Systematic Review 2024-04-18 · Expand citations
    119. Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression 2024-04-15 · Expand citations
    120. Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder 2024-03-07 · Expand citations
    121. Quantification of psilocin in human whole blood using liquid chromatography-tandem mass spectrometry (LC-MS/MS) 2024-03-01 · Expand citations
    122. Psychedelic Mushrooms: The Use of Psilocybin in the Treatment of Mental Disorders 2024-01-01 · Expand citations
    123. Psychedelics: The New Kid on the Block 2024-01-01 · Expand citations
    124. Psilocybin - new remedy for patients with psychiatric disorders? Critical analysis of the current state of knowledge 2023-12-30 · Expand citations
    125. Psychotropics: A scientific, regulatory, and public view on the medicinal uses of cannabinoids and psilocybin 2023-12-11 · Expand citations
    126. Pharmacists’ perspectives on psilocybin in Canada 2023-11-08 · Expand citations
    127. The Potential Therapeutic Benefits and Safety of Psychedelics in the Treatment of Mental Health Conditions: A Systematic Review 2023-11-06 · Expand citations
    128. Songs of Life: Psychedelic-Assisted Psychotherapy and Deleuze and Guattari’s ‘Desiring-Production’ 2023-10-27 · Expand citations
    129. Psilocybin-assisted psychotherapy for the treatment of PTSD in UK armed forces veterans: A feasibility study protocol 2023-10-25 · Expand citations
    130. Christian Responses to Psilocybin-Assisted Therapy and Potential Religious and Spiritual Experiences 2023-10-19 · Expand citations
    131. Can a single dose of psilocybin improve cognitive control in functional dissociative seizures? 2023-09-09 · Expand citations
    132. Psilocybin Use in Palliative Care #464 2023-09-01 · Expand citations
    133. use of psilocybin in the treatment of psychiatric disorders - review 2023-08-15 · Expand citations
    134. Psychedelics reopen the social reward learning critical period 2023-06-13 · Expand citations
    135. A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric history 2023-04-26 · Expand citations
    136. Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairment 2023-04-05 · Expand citations
    137. View, meditation, action: A Tibetan framework to inform psychedelic-assisted therapy 2023-03-28 · Expand citations
    138. Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling 2023-03-01 · Expand citations
    139. The History, Legalization and Potentials of Psilocybin-Assisted Psychotherapy 2023-02-11 · Expand citations
    140. Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial 2023-01-18 · Expand citations
    141. Psychedelic integration challenges: Participant experiences after a psilocybin truffle retreat in the Netherlands 2023-01-16 · Expand citations
    142. Conformational Landscape and Hydrogen Bonding Pattern of Psilocin: Computational Insights 2023-01-09 · Expand citations
    143. The Therapeutic Potential of Psilocybin in Alcohol Use Disorder Recovery: A Literature Review 2023-01-05 · Expand citations
    144. A roadmap for psychedelic pharmacy in Canada: A proposed policy and operations approach for controlled access to select psychedelics for treatment of mental illness 2023-01-01 · Expand citations
    145. Psychedelics for Use and Wellbeing Cultural Context and Recent Developments: A Jamaican Perspective 2022-10-28 · Expand citations
    146. Conformational Landscape and Properties of Psilocybin: A Computational Approach 2022-10-04 · Expand citations
    147. Group Format Psilocybin-Assisted Therapy: Commentary on the HOPE trial (HOPE: a pilot study of psilocybin-enhanced group psychotherapy in patients with cancer) 2022-10-03 · Expand citations
    148. The psychedelic escape from depression 2022-09-27 · Expand citations
    149. Examining Attitudes to Psilocybin: Should Candidates for Medical Psilocybin be Required to Pass a Contextual Suitability Test? 2022-08-18 · Expand citations
    150. Psilocybin and the Meaning Response: Exploring the Healing Process in a Retreat Setting in Jamaica 2022-08-14 · Expand citations
    151. Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions 2022-06-09 · Expand citations
    152. Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats 2022-06-01 · Expand citations
    153. Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin 2022-06-01 · Expand citations
    154. The Efficacy of Psilocybin in the Treatment of Depression andAnxiety: A Meta-Analysis 2022-05-15 · Expand citations
    155. Charismatic, Synchronous and Psychedelic Religious Experiences: A Personal Account 2022-04-07 · Expand citations
    156. Psilocybe mexicana R. Heim - Mexikanischer Kahlkopf 2022-04-01 · Expand citations
    157. Psychedelics hold promise for primary care research 2022-01-24 · Expand citations
    158. Raising awareness: The implementation of medical cannabis and psychedelics used as an adjunct to standard therapy in the treatment of advanced metastatic breast cancer 2022-01-01 · Expand citations
    159. Should Adolescents be Included in Emerging Psychedelic Research? 2022-01-01 · Expand citations
    160. Unravelling a New Conformer of Psilocin Through Computational Methods 2022-01-01 · Expand citations
    161. Conformational Analysis of Psilocybin: A Computational Approach 2021-12-31 · Expand citations
    162. P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot study 2021-12-01 · Expand citations
    163. P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature review 2021-12-01 · Expand citations
    164. Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey 2021-11-03 · Expand citations
    165. New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances 2021-09-17 · Expand citations
    166. A Qualitative Exploration of Relational Ethical Challenges and Practices in Psychedelic Healing 2021-09-16 · Expand citations
    167. The therapeutical role of psychedelic drugs in treatment of mental disorders 2021-09-15 · Expand citations
    168. Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience 2021-09-01 · Expand citations
    169. Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders - integrative review 2021-08-19 · Expand citations
    170. Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa 2021-06-24 · Expand citations
    171. Psychedelics as a Training Experience for Psychedelic Therapists: Drawing on History to Inform Current Practice 2021-06-23 · Expand citations
    172. Whitewashing psychedelics: racial equity in the emerging field of psychedelic-assisted mental health research and treatment 2021-04-29 · Expand citations
    173. Effectiveness of Psilocybin on Depression: A Qualitative Study 2021-04-27 · Expand citations
    174. Four individuals' experiences during and following a psilocybin truffle retreat in the Netherlands 2021-04-16 · Expand citations
    175. Therapeutic Potential of Psychedelics in Treatment of Psychiatric Disorders, Part 2 2021-02-23 · Expand citations
    176. Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma 2021-02-01 · Expand citations
    177. Preclinical Behavioral Assessment of Chronic, Intermittent Low-Dose Psilocybin in Rodent Models of Depression and Anxiety 2021-01-01 · Expand citations
    178. Unmet need in depression: Psilocybin, a breakthrough treatment option 2021-01-01 · Expand citations
    179. The Effect of Psilocybin on Personality 2020-12-31 · Expand citations
    180. Advancing elite athlete mental health treatment with psychedelic-assisted psychotherapy 2020-11-10 · Expand citations
    181. The Role of Psychedelics and Counseling in Mental Health Treatment 2020-10-01 · Expand citations
    182. Case Report: Resolution of Rheumatoid Arthritis in a Patient Consuming Psilocybin Mushrooms 2020-08-19 · Expand citations
    183. Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of Psilocybin 2020-07-14 · Expand citations
    184. A potential role for psilocybin in the treatment of obsessive-compulsive disorder 2020-06-01 · Expand citations
    185. Isness: Using Multi-Person VR to Design Peak Mystical Type Experiences Comparable to Psychedelics 2020-04-20 · Expand citations
    186. An Improved, Practical, and Scalable Five-Step Synthesis of Psilocybin 2020-01-08 · Expand citations
    187. Reported effects of psychedelic use on those with low well-being given various emotional states and social contexts 2020-01-01 · Expand citations
    188. Psilocybin for depression: Considerations for clinical trial design 2019-09-01 · Expand citations
    189. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels 2019-06-01 · Expand citations
    190. Psychedelic-assisted therapy for anxiety and depression in the face of death: A critical review with an anthropological lens 2019-02-25 · Expand citations
    191. 2018: A watershed year for psychedelic science 2019-01-01 · Expand citations
    192. Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humans 2019-01-01 · Expand citations
    193. The influence of therapists’ first-hand experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training 2018-10-05 · Expand citations
    194. NATURALIZING PSYCHEDELIC SPIRITUALITY 2017-08-18 · Expand citations
    195. Developing Guidelines and Competencies for the Training of Psychedelic Therapists 2017-06-29 · Expand citations
    196. Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression 2017-06-19 · Expand citations
    197. Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress 2017-06-14 · Expand citations
    198. Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis 2017-04-28 · Expand citations
    199. Should addiction researchers be interested in psychedelic science? 2017-04-10 · Expand citations